Back to Search Start Over

In Vivo Imaging of Hypoxia and Neoangiogenesis in Experimental Syngeneic Hepatocellular Carcinoma Tumor Model Using Positron Emission Tomography.

Authors :
Kis, Adrienn
Szabó, Judit P.
Dénes, Noémi
Vágner, Adrienn
Nagy, Gábor
Garai, Ildikó
Fekete, Anikó
Szikra, Dezső
Hajdu, István
Matolay, Orsolya
Méhes, Gábor
Mező, Gábor
Kertész, István
Trencsényi, György
Source :
BioMed Research International; 8/7/2020, p1-10, 10p
Publication Year :
2020

Abstract

Introduction. Hypoxia-induced α<subscript>ν</subscript>β<subscript>3</subscript> integrin and aminopeptidase N (APN/CD13) receptor expression play an important role in tumor neoangiogenesis. APN/CD13-specific <superscript>68</superscript>Ga-NOTA-c(NGR), α<subscript>ν</subscript>β<subscript>3</subscript> integrin-specific <superscript>68</superscript>Ga-NODAGA-[c(RGD)]<subscript>2</subscript>, and hypoxia-specific <superscript>68</superscript>Ga-DOTA-nitroimidazole enable the in vivo detection of the neoangiogenic process and the hypoxic regions in the tumor mass using positron emission tomography (PET) imaging. The aim of this study was to evaluate whether <superscript>68</superscript>Ga-NOTA-c(NGR) and <superscript>68</superscript>Ga-DOTA-nitroimidazole allow the in vivo noninvasive detection of the temporal changes of APN/CD13 expression and hypoxia in experimental He/De tumors using positron emission tomography. Materials and Methods. 5 × 10 6 hepatocellular carcinoma (He/De) cells were used for the induction of a subcutaneous tumor model in Fischer-344 rats. He/De tumor-bearing animals were anaesthetized, and 90 min after intravenous injection of 10.2 ± 1.1 MBq <superscript>68</superscript>Ga-NOTA-c(NGR) or <superscript>68</superscript>Ga-NODAGA-[c(RGD)]<subscript>2</subscript> (as angiogenesis tracers) or <superscript>68</superscript>Ga-DOTA-nitroimidazole (for hypoxia imaging), whole-body PET/MRI scans were performed. Results. Hypoxic regions and angiogenic markers (α<subscript>v</subscript>β<subscript>3</subscript> integrin and APN/CD13) were determined using <superscript>68</superscript>Ga-NOTA-c(NGR), <superscript>68</superscript>Ga-DOTA-nitroimidazole, and <superscript>68</superscript>Ga-NODAGA-[c(RGD)]<subscript>2</subscript> in subcutaneously growing He/De tumors in rats. <superscript>68</superscript>Ga-NOTA-c(NGR) showed the strong APN/CD13 positivity of He/De tumors in vivo, by which observation was confirmed by western blot analysis. By the qualitative analysis of PET images, heterogenous accumulation was found inside He/De tumors using all radiotracers. Significantly (p ≤ 0.01) higher SUVmean and SUVmax values were found in the radiotracer avid regions of the tumors than those of the nonavid areas using hypoxia and angiogenesis-specific radiopharmaceuticals. Furthermore, a strong correlation was found between the presence of angiogenic markers, the appearance of hypoxic regions, and the tumor volume using noninvasive in vivo PET imaging. Conclusion. <superscript>68</superscript>Ga-DOTA-nitroimidazole and <superscript>68</superscript>Ga-NOTA-c(NGR) are suitable diagnostic radiotracers for the detection of the temporal changes of hypoxic areas and neoangiogenic molecule (CD13) expression, which vary during tumor growth in a hepatocellular carcinoma model. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
23146133
Database :
Complementary Index
Journal :
BioMed Research International
Publication Type :
Academic Journal
Accession number :
145035326
Full Text :
https://doi.org/10.1155/2020/4952372